• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC PARASITE PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC PARASITE PANEL; GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 442960
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/12/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after use with bd max¿ enteric parasite panel 2 false negative results were reported.Confirmatory testing from two other independent methods were positive.There was no patient impact.The following information was provided by the initial reporter: customer reported contrasting results for cryptosporidium using bd max (negative) compared with two independent methods: qiagen (positive ct 37) and an in-house method (positive ct 33).When did the incident occur? after use.
 
Manufacturer Narrative
The following field was updated with corrected information: b.5.Describe event or problem: it was reported that after use with bd max¿ enteric parasite panel false negative results were reported.Confirmatory testing from two other independent methods were positive.There was no patient impact.Report 1 of 2.H.6.Investigation summary: the complaint investigation for discrepant results with the bd max¿ enteric parasite panel kit (ref.(b)(4) lot 3005954 was performed by the review of manufacturing records, retain material testing, review of customer¿s data, and by the complaint¿s history review.Review of the manufacturing records of bd max enteric parasite panel indicated that the lot 3005954 was manufactured according to specifications and met performance requirements.The retain material of bd max¿ enteric parasite panel kit from lot 3005954 was tested and the results were as expected.Customer complained about a discrepant cryptosporidium (crypto) negative result with the bd max¿ enteric parasite panel kit lot 3005954.According to customer, three confirmatory testing with alternative methods (qiastat-dx gi panel from qiagen and in-house pcr) gave positive crypto results with cts of 37.5, 37.6 and 33.9.Customer provided three screenshots of the pdf report of run 759 performed on bd max¿ instrument ct2185, consisting of two samples (a6 and a7) that gave negative result for all the targets, and one picture showing ct results from alternative detection method testing (in-house pcr; ct 37.610 and 33.966).Following request made by the investigation team, run 759 csv file, and run 773 pdf and csv files (repeat test) were provided by customer.Manual pcr curve adjudication was performed on run 759 and show no amplification in the rox channel (crypto target) with no anomaly.Further communication with customer also revealed that customer applied a modified preparation of solid sample.A repeat test on the bd max¿, while following exactly the sample preparation method stated in the package insert of the assay (pi; p0219), was performed in run 773 position a3 and gave a positive crypto target result (ct 32.8).Analysis of the pcr curve in the rox channel (crypto target) revealed a late true amplification and no anomaly.Based on the available information and the investigation, off label sample preparation is suspected of being the cause for the customer¿s discrepant result.Bd is unable to identify the exact cause of the customer¿s issue, but no reagents issue is suspected.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max¿ enteric parasite panel kit lot 3005954.The root cause was not identified.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action plan (capa) since no new hazard was identified.
 
Event Description
It was reported that after use with bd max¿ enteric parasite panel false negative results were reported.Confirmatory testing from two other independent methods were positive.There was no patient impact.Report 1 of 2 the following information was provided by the initial reporter: customer reported contrasting results for cryptosporidium using bd max (negative) compared with two independent methods: qiagen (positive ct 37) and an in-house method (positive ct 33).When did the incident occur? after use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC PARASITE PANEL
Type of Device
GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17484768
MDR Text Key321538374
Report Number3007420875-2023-00073
Device Sequence Number1
Product Code PCH
UDI-Device Identifier00382904429607
UDI-Public(01)00382904429607
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K143648
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number442960
Device Lot Number3005954
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/24/2023
Initial Date FDA Received08/08/2023
Supplement Dates Manufacturer Received08/28/2023
Supplement Dates FDA Received08/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-